Drug Therapy, B-Adrenoceptor Antagonists:New Drugs & New Indications
NEJM 305:500-506, Frishman,W.H., 1981
Midodrine, A New Agent in the Management of Idiopathic Orthostatic Hypotension & Shy-Drager Syndrome
Mayo Clin Proc 56:429-433, Schirger,A.,et al, 1981
Diagnosis & Treatment, Physiologic & Pathologic Tremors
Ann Int Med 93:460-465, Jankovic,J.,et al, 1980
Metoprolol in Essential Tremor
Arch Neurol 37:596-597, Newman,R.R.,et al, 1980
Treatment Of Migraine With Metoprolol
NEJM 303:156-157, Ljung,O., 1980
Proximal Myopathy During Beta-blockade
BMJ 2:1331-1332, Forfar,J.C.,et al, 1979
Beneficial Effect of Propranolol in Familial Ataxia
Ann Neurol 5:207, Braham,J.,et al, 1979
Organic Brain Syndrome with Propranolol
NEJM 300:366, Kurland,M.L., 1979
Metopropol For Essential Tremor
NEJM 301:331, Britt,C.W.Jr.,et al, 1979
Treatment Of Essential Tremor With Metopropol
NEJM 301:1005, Ljung,O., 1979
Successful Treatment of Narcolepsy with Propranolol
Arch Neurol 36:650-651, Kales,A.,et al, 1979
Disorders of Neuromuscular Transmission Caused by Drugs
NEJM 301:409-413, Argov,Z.,et al, 1979
Seizures & Intraventricular Conduction Defect in Propranolol Poisoning
Ann Int Med 91:860-862, Buiumsohn,A.,et al, 1979
Propranolol for Severe Post-head Injury Action Tremor
Neurol 28:197, Ellison,P.H., 1978
Newer Concepts in Management of Migraine Headaches
J Med Soc N J 74:11, Haidri,N.H.,et al, 1977
Posttraumatic Dysautonomic Cephalgia
Arch Neurol 32:649, Vijayan,N.,et al, 1975
Non-Beta Blocking Action of Propranolol
NEJM 293:988, Koch-Weser,J., 1975
Efficacy of Chronic Propranolol Therapy in Action Tremors of the Familial, Senile or Essential Varieties
NEJM 290:984, Winkler,G.,et al, 1974
Ptosis-Toxiocology of the Eye
p 814, , 1974
Treatment of Essential Tremor with Propranolol
Lancet 205, Jan1973., , 1973
Benign Essential Tremor
Lancet 471, 1972 Sept., , 1972
Isolated Ophthalmic Migraine:Its Frequency, Mechanism & Diff. Diagnosis
Neuro-Ophthalmol 1972-Bascom Palmer Instit Symp, Ed, J. S. Smith., Hedges,T., 1972
Treatment of Parkinsonism
NEJM 287:1047, Young,R.R., 1972
Combined Treatment of Parkinsonian Tremor with Propranolol & Levodopa
J Neurol Sci 14:491, , 1971
Monocular Diplopia:Its Characteristics & Response to Guanethidine
Am J Ophthalmol 63:459, Hales,R., 1967
Neurovascular Complications of Iatrogenic Fusarium solani Meningitis
NEJM 390:522-529, Strong, N.,et al, 2024
Clinical,Neuroimaging,and Genetic Markers in Cerebral Amyloid Angiopatny-Related Inflammation:A Systematic Review and Meta-Analusis
Stroke 54:178-188, Theodorou,A.,et al, 2023
Lecanemab in Early Alzheimers Disease
NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023
Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
JAMA 330:512-517, 510, Sims,J.R.,et al, 2023
Atogepant for the Preventive Treatment of Chronic Migraine (PROGRESS): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lancet 402:775-785, Pozo-Rosich,P.,et al, 2023
Blook Transfusion and Brain Amyloidosis, Should We Be Worried?
JAMA 330:921-922, Greenberg,S.M., 2023
Clinicopathological Conference, Chronic Candida Albicans Meningitis
NEJM 387:641-650, Case 25-2022, 2022
Alzheimers Disease
Lancet 397:1577-1590, Scheltens, P.,et al, 2021
Headache, Cognitive Decline, and a Curious Rim-Enhancing Lesion
JAMA Neurol 78:613-614, Beaman, C.B.,et al, 2021
Acute Treatment for Migraine
JAMA 325:2346-2347, Burch, R. & Rayhill, M., 2021
Clinicopathologic Conference, Cerebral Amyloid Angiopatny-Related Inflammation
NEJM 385:358-368, Case 22-2021, 2021
Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab
NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021
Atogepant for the Preventive Treatment of Migraine
NEJM 385:695-706, Ailani,J.,et al, 2021
Chronic Meningitis
NEJM 385:930-936, Aksamit, A.J., 2021
Infection Risks Among Patients with Multiple Sclerosis Treated with Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
JAMA Neurol 77:184-191, Luna, G.,et al, 2020
Clinicopathologic Conference, AA Amyloidosis, Complicated by Cerebral Mucormycosis
NEJM 382:1457-1466, Case 11-2020, 2020
An 81-year-old Woman with Decreased Consciousness and Fluctuating Right Facial Droop
Neurol 94:843-848, Van Ommeren, R.,et al, 2020
MR Target Sign in Cerebral Aspergillosis
Neurohospitalist doi:10.1177/1941874420929191, Finelli, P.F., 2020
One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020
A 73-Year-Old Man with Recurrent Aphasia, Headaches, and Confusion
Neurol 95:e2595-e2599, Bose, G.,et al, 2020
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
Cerebral Microbleeds
Neurol 92:e253-e262, Graff-Radford, J.,et al, 2019
Erenumab in Chronic Migraine
Neurol 92:e2250-e2260, Lipton, R.B.,et al, 2019
Remigepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
NEJM 381:142-149, Lipton, R.B.,et al, 2019
Trial of Galcanezumab in Prevention of Episodic Cluster Headache
NEJM 381:132-141, Goadsby, P.J.,et al, 2019